Patents held 

1. International Patent Filing (PCT/SG2018/050075), August 2018 (WO 2018/151681 A1). US Patent Application No: 16/485,973, Aug. 2019. South Africa Patent Application 2019/06047, 2019; Compounds for Treating Tuberculosis; Inventors: G. Grüber, R.W. Bates, A. Hotra, T. Dick, K. Pethe

2. Singapore “Provisional” Patent (10201807627U), Sep. 2018; Unravelling the essentials of subunit ε of mycobacterial F-ATP synthases for proper cell growth of the pathogen and novel inhibitors of mycobacterial F-ATP synthases; Inventors: G. Grüber, R.W. Bates, V.K.H. Amaravadhi, P. Ragunathan, W.G. Saw, J. Shin, P. Sae-Lao

3. Singapore “Provisional” Patent 10201911205R, Nov. 2019, and International Patent Filing (PCT/SG2020/050695), Nov. 2020; Anti-Tubercular Compounds; Inventors: G. Grüber, R.W. Bates, P.S. Ng

4. Singapore (SG) “Provisional” Patent (Application Number 10202104853U), 10th May 2021; Identifying The Essentials Of Subunit δ Of Mycobacterial F-ATP Synthases For Proper ATP Synthesis And A Novel Inhibitor Of Mycobacterial F-ATP Synthases; Inventors: G. Grüber, V.K.H. Amaravadhi, W.G. Saw, P. Ragunathan

5. Singapore (SG) “Provisional” Patent (Application Number 10202110405X), 21st September 2021; Atomic Insight Into Coupling Subunit ε of Mycobacterium abscessus's F-ATP Synthase And Design Of A Potent Mycobacterium abscessus Growth Inhibitor Targeting The Engine. G. Grüber, J. Shin, V.K.H. Amaravadhi, C.F. Wong, P. Ragunathan

6. Singapore (SG) “Provisional” Patent (Application Number 10202108980T), 29th October 2021; Discovery Of A F-ATP Synthase Inhibitor For The Treatment Of Mycobacterium abscessus Diseases; Inventors: G. Grüber, R.W. Bates, P. Ragunathan

7. Singapore (SG) “Provisional” Patent (Application Number 10202203339W), 1st April 2022; GaMF1.39's Enhanced Antitubercular Activity In Combination With Anti-Tubercular Drugs Targeting The Oxidative Phosphorylation Pathway; Inventors: G. Grüber, R.W. Bates, S.P. Ng